GlaxoSmithKline (CAI:BIOC) Common Stock: E£835 Mil (As of Sep. 2016)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is GlaxoSmithKline Common Stock?

GlaxoSmithKline CAI:BIOC +16.60% Common Stock is E£835 Mil as of Sep. 2016.

GlaxoSmithKline's quarterly common stock stayed the same from Mar. 2016 (E£835 Mil) to Jun. 2016 (E£835 Mil) and stayed the same from Jun. 2016 (E£835 Mil) to Sep. 2016 (E£835 Mil).

GlaxoSmithKline's annual common stock stayed the same from Dec. 2013 (E£835 Mil) to Dec. 2014 (E£835 Mil) and stayed the same from Dec. 2014 (E£835 Mil) to Dec. 2015 (E£835 Mil).

GlaxoSmithKline Common Stock Historical Data

* Premium members only.

The historical data trend for GlaxoSmithKline's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GlaxoSmithKline Common Stock Chart

GlaxoSmithKline Annual Data
Trend Dec12 Dec13 Dec14 Dec15
Common Stock
835.14 835.14 835.14 835.14

GlaxoSmithKline Quarterly Data
Dec12 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 835.14 835.14 835.14 835.14 835.14

GlaxoSmithKline Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of E£835 Mil mean?
GlaxoSmithKline (CAI:BIOC) has a Common Stock of E£835 Mil as of Sep. 2016. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on GlaxoSmithKline and its competitors.
Is GlaxoSmithKline's Common Stock too high?
GlaxoSmithKline's current Common Stock is E£835 Mil.
How does GlaxoSmithKline's Common Stock compare to PRPH?
GlaxoSmithKline's Common Stock of E£835 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on GlaxoSmithKline and its competitors. GlaxoSmithKline's current Common Stock is E£835 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GlaxoSmithKline stock overvalued right now?
GlaxoSmithKline (CAI:BIOC) has a current Common Stock of E£835 Mil. The current Common Stock is E£835 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For GlaxoSmithKline (CAI:BIOC), the current Common Stock is E£835 Mil as of Sep. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GlaxoSmithKline Business Description

Address Boomerang Building, No 46, Block (J) First Section City Centre, Town Centre, Second floor, Fifth District - New Cairo, Cairo, EGY, 11835
GlaxoSmithKline is a pharmaceutical company. It is focused on developing new medicines in respiratory, HIV, oncology, and immune-inflation. The company is segmented into Commercial Operations and Total Research and development. It generates the majority of its revenue from the Commercial Operations segment.